/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES
OR DISSEMINATION IN THE UNITED
STATES/
Abba Medix Corp. to distribute Rubicon
Organics' concentrate products through existing provincial
distribution channels
TORONTO, Oct. 26, 2020 /CNW/ - Canada House Wellness Group
(CSE: CHV) ("Canada House" or the "Company"), a fully
integrated medical cannabis company, is pleased to
announce that it has entered into a Cannabis 2.0
distribution agreement (the "Agreement") with Rubicon
Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) ("Rubicon
Organics"). Under the terms of the Agreement, Canada
House's wholly owned subsidiary, Abba Medix
Corp. ("Abba"), will distribute Rubicon Organics' line
of concentrate products through its established provincial
distribution channels.
"Since receiving our Cannabis 2.0 sales license we have been
developing and internally producing Cannabis 2.0 products for our
existing distribution channels with a focus on military veterans,"
said Chris Churchill-Smith, Canada
House CEO. "This Agreement allows us to partner with an
industry leading Licensed Producer to leverage their outstanding
line of organic concentrates while validating our distribution
channels and the path to market for our own high margin cannabis
oil, rosin, and other concentrate products."
About Canada House Wellness Group
Canada House Wellness Group is the parent company of Abba Medix
Corp., a Licensed Producer in Pickering,
Ontario that produces high quality medical grade cannabis;
IsoCanMed Inc., a Licensed Producer in Louiseville, Québec growing best-in-class
indoor cannabis, in its 64,000 sq. ft. production facility
employing state-of-the-art vertical, aeroponic production
methodologies; Canada House Clinics Inc., with clinics across the
country that work directly with primary care teams to provide
specialized cannabinoid therapy services to patients suffering from
simple and complex medical conditions; and Knalysis Technologies, a
provider of fully customizable, cloud-based software that links
physician, provider, and patient to data that supports treatment
with medical cannabis.
Canada House Wellness Group's goal is to become the leading
cultivator of premium craft cannabis and provider of cannabinoid
therapy, targeting the medical cannabis markets globally. Please
visit www.canadahouse.ca or the Company's public filings at
www.sedar.com.
About Rubicon Organics Inc.
Rubicon Organics Inc. is becoming the global brand leader in
organic cannabis products. Through its wholly owned subsidiary
Rubicon Holdings Corp, a licensed producer, the Company cultivates
and sells organic certified, sustainably grown, super-premium
cannabis from its state-of-the-art hybrid greenhouse located in
Delta, BC, Canada. Rubicon Organics is focused on
achieving industry leading profitability through the development of
brands and cannabis 2.0 products, including its flagship
super-premium brand Simply BareTM Organic.
Cautionary Statement Regarding Forward-Looking Information. This
press release contains forward- looking statements, including
statements that relate to, among other things, the Company's
clinic, production and technology businesses, its future plans, the
Company's markets, objectives, goals, strategies, intentions,
beliefs, expectations and estimates, and can generally be
identified by the use of words such as "may", "will",
"could", "should", "would", "likely", "possible", "expect",
"intend", "estimate", "anticipate", "believe", "plan", "objective"
and "continue" (or the negative thereof) and words and expressions
of similar import. Although the Company believes that the
expectations reflected in such forward-looking statements are
reasonable, such statements involve risks and uncertainties, and
undue reliance should not be placed on such statements. Certain
material factors or assumptions are applied in making
forward-looking statements, and actual results may differ
materially from those expressed or implied in such statements.
Material assumptions used to develop forward-looking information in
this news release include, among other things, the regulations
related to cannabis use under the Access to Cannabis for Medical
Purposes Regulations and the act respecting cannabis and to amend
the Controlled Drugs and Substances Act, the Criminal Code and
other Acts, passed by the Canadian Federal government, making
cannabis and cannabis based edibles, vapes and oils legal for
recreational use on October 17, 2018
and October 17, 2019; Company
liquidity and capital resources, including the availability of
additional capital resources to fund its activities; level of
competition; the ability to adapt products and services to the
changing market; the ability to attract and retain key executives;
and the ability to execute strategic plans. Additional information
about material factors that could cause actual results to differ
materially from expectations and about material factors or
assumptions applied in making forward-looking statements may be
found in the Company's most recent annual and interim Management's
Discussion and Analysis under "Risk and Uncertainties" as well as
in other public disclosure documents filed with Canadian securities
regulatory authorities. The Company does not undertake any
obligation to update publicly or to revise any of the
forward-looking statements contained in this document, whether as a
result of new information, future events or otherwise, except as
required by law.
Neither the CSE nor its Regulation Services Provider (as that
term is defined in the policies of the CSE) accepts responsibility
for the adequacy or accuracy of this release.
SOURCE Canada House Wellness Group Inc.